إعلان
إعلان
MRKR
Marker Therapeutics, Inc. Common Stock
2.01
USDبرعاية
-0.06
-2.80%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
2.04
+0.03
+1.64%
تقارير أرباح MRKR
النسبة الإيجابية المفاجئة
MRKR تفوق 18 من 26 آخر التقديرات.
69%
التقرير التالي
بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$695.64K
/-$0.20
التغير الضمني من Q3 25 (Revenue/ EPS)
-43.58%
/+66.67%
التغير الضمني من Q4 24 (Revenue/ EPS)
-69.11%
/-52.38%
Marker Therapeutics, Inc. Common Stock earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, MRKR reported earnings of -0.12 USD per share (EPS) for Q3 25, beating the estimate of -0.45 USD, resulting in a 73.86% surprise. Revenue reached 1.23 مليون, compared to an expected 737.46 ألف, with a 67.20% difference. The market reacted with a +3.48% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of -0.20 USD, with revenue projected to reach 695.64 ألف USD, implying an زيادة of 66.67% EPS, and نقصان of -43.58% in Revenue from the last quarter.
الأسئلة الشائعة
What were Marker Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Marker Therapeutics, Inc. Common Stock reported EPS of -$0.12, beating estimates by 73.86%, and revenue of $1.23M, 67.2% above expectations.
How did the market react to Marker Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 3.48%, changed from $0.89 before the earnings release to $0.92 the day after.
When is Marker Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
What are the forecasts for Marker Therapeutics, Inc. Common Stock's next earnings report?
Based on 5
المحللين, Marker Therapeutics, Inc. Common Stock is expected to report EPS of -$0.20 and revenue of $695.64K for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان